Clinical Trials Browser

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Glioblastoma

Brain Neoplasms, Glioma, Neoplasms, Spinal Cord Neoplasms

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma, Glioma

Astrocytoma, Glioblastoma, Glioma

Paraganglioma, Pheochromocytoma

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

Glioblastoma, Gliosarcoma

Glioblastoma, Gliosarcoma

Glioblastoma

Brain Neoplasms, Melanoma, Pancreatic Neoplasms

Neuroblastoma

Brain Neoplasms, Glioblastoma

Glioblastoma

Ependymoma, Medulloblastoma, Recurrence

Neuroblastoma

Neuroblastoma

Glioblastoma

Ependymoma, Medulloblastoma

Glioblastoma

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Glioblastoma

Glioblastoma

Primary Glioblastoma

Glioblastoma

Astrocytoma, Glioblastoma, Oligodendroglioma

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Glioblastoma, Medulloblastoma

Neuroblastoma

Glioblastoma

Brain Neoplasms, Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma

Paraganglioma, Pheochromocytoma

Glioblastoma, Glioma, Gliosarcoma

Glioblastoma

Glioblastoma, Glioma

Neuroblastoma, Ganglioneuroblastoma

Glioblastoma, Meningeal Carcinomatosis

Glioblastoma

Glioblastoma

Glioblastoma

Glioblastoma, Glioma

Glioblastoma, Gliosarcoma

Clinical Trials

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

A Clinical Trial Testing the Safety of the Investigational Drug Pumitamig (BNT327) and How Well it Works in Patients With Recurrent Glioblastoma

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

Surgical Pembro +/- Olaparib w TMZ for rGBM

MEMMAT

Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

2-THE-TOP

131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma

Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

ARISTOCRAT

A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)

Neoantigen-Pulsed Autologous Dendritic Cell Vaccine Combined With Temozolomide for Newly Diagnosed Glioblastoma

MATVAC-1

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG

Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children

Newly Diagnosed Glioblastoma

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

VIGAS2

Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

OPTIMUM

hSTAR GBM

Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

NeoGlio

Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)

18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

Stupp Treatment With Intrathecal Injection of Thiotepa for Glioblastoma With Advanced Spread

G-CSF After Chemo-radiation in Patients With Glioblastoma

GBM

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

IMAGLIO

Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma

Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)

Spectroscopic MRI-Guided Radiation Therapy Planning in Glioblastoma